JACC: Cardiovascular Interventions - 5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results
Commentary by Drs. Megha Prasad and Mayra E. Guerrero

Commentary by Drs. Megha Prasad and Mayra E. Guerrero
Commentary by Drs. Pratik Doshi and ACC Past-President Dipti Itchhaporia discussing her experience in Amsterdam during the 2023 ESC Congress and how we can apply the science into clinical practice.
Commentary by Dr. Julia Grapsa
Carl June, MD discusses the future of immunotherapy for cancer and cardiovascular disease, potential adverse cardiovascular effects of CAR-T therapy, and provides advice to aspiring physician-scientists. Moderated by Nicholas Wilcox, MD, MHS.
Kerry Reynolds, MD, and Han Zhu, MD, discuss the role of biomarkers in surveillance and management of cardiovascular IRAEs and review future directions in the field of IRAEs. Moderated by Sarah Waliany, MD, MS.
Roxana Mehran, MD discusses her career in clinical trials, improving representation of women in leadership roles, and advice to junior trainees. Moderated by Alex Murphy, MD, PhD.
Commentary by Dr. Edward Gerstenfeld
Commentary by Dr. Julia Grapsa
Commentary by Drs. Julia Grapsa, Edoardo Zancanaro, and Yevgeniy Brailovsky
Montserrat Carrillo-Estrada, MD discusses her experience starting a cardio-oncology program in Mexico and reviews the current landscape of cardio-oncology clinical care and research in Mexico. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.
Darryl Leong, MBBS, MPH M.Biostat, PhD, discusses cardiovascular risks in men with prostate cancer and reviews critical topics such as comparative risk of GnRH agonists versus antagonists. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.
Paolo Bima, MD and Professor Christian E. Mueller MD, FESC discuss key takeaways from their study on prevalence of myocardial infarction in cancer patients and review the clinical implications of their findings. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.
Alexander Lyon, MA, BM BCh, PhD, Co-Chair of 2022 ESC Cardio-Oncology Guidelines, reflects on key takeaways from the guidelines and the impact of the guidelines on the field of cardio-oncology. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.
Teresa López-Fernández, MD, Co-Chair of 2022 ESC Cardio-Oncology Guidelines, reflects on key takeaways from the guidelines, changes in perspectives over the past year, and future directions in cardio-oncology. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.
Commentary by Drs. Abdullah Al-Abcha and Alasnag
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Edward Gerstenfeld
Commentary by Dr. Edward Gerstenfeld
Commentary by Dr. Julia Grapsa
Audio Summary of the August 1, 2023 Issue by Dr. Jian'an Wang
Commentary by Dr Atsushi Nohara
JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, discusses ongoing work to advance equity in cardio-oncology clinical care, research and training with Clyde Yancy, MD, MSc, MACC.
Commentary by Dr Yukio Ozaki
Commentary by Dr Jian-Jun Li